| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| IL2-H52H4 | Human | Human IL-1 Rrp2 / IL-1 R6 (C154S, C262S) Protein, His Tag (MALS verified) |  |
|
|
| IL2-C52H5 | Cynomolgus | Cynomolgus IL-1 Rrp2 / IL-1 R6 Protein, His Tag |  |
|
|
| IL2-H5254 | Human | Human IL-1 Rrp2 / IL-1 R6 Protein, Fc Tag |  |
|
|
| IL2-H52H6 | Human | Human IL-1 Rrp2 / IL-1 R6 Protein, His Tag |  |
|
|
Immobilized Recombinant Human IL-36Ra / IL-1F5 at 2 μg/mL (100 μL/well) can bind Human IL-1 Rrp2, Fc Tag (Cat. No. IL2-H5254) with a linear range of 0.156-5 μg/mL (QC tested).
The purity of Human IL-1 Rrp2 (C154S, C262S), His Tag(Cat. No. IL2-H52H4) is more than 90% and the molecular weight of this protein is around 50-65 kDa verified by SEC-MALS.
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Imsidolimab | ANB-019 | Phase 2 Clinical | Anaptysbio | Acne Vulgaris; Ichthyosis; Psoriasis; Acneiform Eruptions; Hidradenitis Suppurativa | Details |
| Spesolimab | BI-655130 | Phase 3 Clinical | C.H. Boehringer Sohn Ag & Co. Kg | Psoriasis; Colitis, Ulcerative; Hidradenitis Suppurativa; Dermatitis, Atopic; Crohn Disease | Details |
This web search service is supported by Google Inc.
A-Z
